Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-05-18 20:32:36 ET · period of report 2026-05-15 · accession 0001547959-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-18 20:32 | 2026-05-15 | MIRM | Ramasastry Saira | Dir | M - OptEx | $23.51 | +2,000 | 2,000 | New | +$47.0K |
| DT | 2026-05-18 20:32 | 2026-05-15 | MIRM | Ramasastry Saira | Dir | S - Sale+OE | $109.47 | -2,000 | 0 | -100% | -$218.9K |
| DT | 2026-05-18 20:32 | 2026-05-15 | MIRM | Ramasastry Saira | Dir | M - OptEx | $0.00 | -2,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | M | A | 2,000 | $23.51 | 2,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-15 | S | D | 2,000 | $109.47 | 0 | D | — | — | (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025. |
| 3 | Derivative | Stock Option (right to buy) | 2026-05-15 | M | D | 2,000 | $0.00 | 0 | D | $23.51 · — to 2032-06-01 | 2,000 Common Stock | (F2) The stock option is fully vested. |